Recent publications

  1. Allen AS, Berkovic S, Bridgers J, Cossette P, Dlugos D, Epstein MP, Glauser T, Goldstein DB, Heinzen EL, Jiang Y, Johnson MR, Kuzniecky R, Lowenstein DH, Marson AG, Mefford HC, O'Brien T, Ottman R, Petrou S, Petrovski S, Poduri A, Ren Z, Scheffer I, Sherr E, Wang Q, Balling R, Barisic N, Baulac S, Caglayan H, Craiu D, De Jonghe P, Depienne C, Guerrini R, Helbig I, Hjalgrim H, Hoffman-Zacharska D, Jaehn J, Klein KM, Koeleman B, Komarek V, Krause R, Leguern E, Lehesjoki A-E, Lemke JR, Lerche H, Linnankivi T, Marini C, May P, Moller RS, Muhle H, Pal D, Palotie A, Rosenow F, Selmer K, Serratosa JM, Sisodiya S, Stephani U, Sterbova K, Striano P, Suls A, Talvik T, Von Spiczak S, Weber Y, Weckhuysen S, Zara F, Abou-Khalil B, Alldredge BK, Amrom D, Andermann E, Andermann F, Bautista JF, Berkovic S, Bluvstein J, Cascino GD, Consalvo D, Crumrine P, Devinsky O, Dlugos D, Epstein MP, Fiol ME, Fountain NB, French J, Friedman D, Glauser T, Haas K, Haut SR, Hayward J, Joshi S, Kanner A, Kirsch HE, Kossoff EH, Kuperman R, Kuzniecky R, Lowenstein DH, McGuire SM, Motika PV, Novotny EJ, Ottman R, Paolicchi JM, Parent J, Park K, Poduri A, Scheffer I, Shellhaas RA, Sherr E, Sirven J, Smith MC, Sullivan J, Thio LL, Venkat A, Vining EPG, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR. Application of rare variant transmission disequilibrium tests to epileptic encephalopathy trio sequence data. EUROPEAN JOURNAL OF HUMAN GENETICS. Nature Publishing Group. 2017, Vol. 25, Issue 7.
  2. Tae H-S, Smith KM, Phillips AM, Boyle KA, Li M, Forster IC, Hatch R, Richardson R, Hughes DI, Graham BA, Petrou S, Reid C. Gabapentin Modulates HCN4 Channel Voltage-Dependence. FRONTIERS IN PHARMACOLOGY. Frontiers Research Foundation. 2017, Vol. 8, Issue AUG.
  3. Hatch R, Mendis G, Kaila K, Reid C, Petrou S. Gap Junctions Link Regular-Spiking and Fast-Spiking Interneurons in Layer 5 Somatosensory Cortex. FRONTIERS IN CELLULAR NEUROSCIENCE. Frontiers Research Foundation. 2017, Vol. 11.
  4. Semple B, O'Brien T, Gimlin K, Wright D, Kim SE, Casillas-Espinosa PM, Webster K, Petrou S, Noble-Haeusslein LJ. Interleukin-1 Receptor in Seizure Susceptibility after Traumatic Injury to the Pediatric Brain. JOURNAL OF NEUROSCIENCE. Society of Neuroscience. 2017, Vol. 37, Issue 33.
  5. Li M, Milligan CJ, Wang H, Walker A, Churilov L, Lawrence A, Reid C, Hopkins SC, Petrou S. KCTD12 modulation of GABA(B) receptor function. Pharmacology Research and Perspectives. 2017, Vol. 5, Issue 4.
  6. Oliver K, Franceschetti S, Milligan CJ, Muona M, Mandelstam SA, Canafoglia L, Boguszewska-Chachulska AM, Korczyn AD, Bisulli F, Di Bonaventura C, Ragona F, Michelucci R, Ben-Zeev B, Straussberg R, Panzica F, Massano J, Friedman D, Crespel A, Engelsen BA, Andermann F, Andermann E, Spodar K, Lasek-Bal A, Riguzzi P, Pasini E, Tinuper P, Licchetta L, Gardella E, Lindenau M, Wulf A, Moller RS, Benninger F, Afawi Z, Rubboli G, Reid C, Maljevic S, Lerche H, Lehesjoki A-E, Petrou S, Berkovic S. Myoclonus Epilepsy and Ataxia due to KCNC1 Mutation: Analysis of 20 Cases and K plus Channel Properties. ANNALS OF NEUROLOGY. Wiley-Liss. 2017, Vol. 81, Issue 5.
  7. Stamp L, Gwynne RM, Foong JPP, Lomax AE, Hao M, Kaplan DI, Reid C, Petrou S, Allen AM, Bornstein JC, Young H. Optogenetic Demonstration of Functional Innervation of Mouse Colon by Neurons Derived From Transplanted Neural Cells. GASTROENTEROLOGY. WB Saunders Co. 2017, Vol. 152, Issue 6.
  8. Sadovnick AD, Gu B, Traboulsee AL, Bernales CQ, Encarnacion M, Yee IM, Criscuoli MG, Huang X, Ou A, Milligan CJ, Petrou S, Wiley JS, Vilarino-Guell C. Purinergic receptors P2RX4 and P2RX7 in familial multiple sclerosis. HUMAN MUTATION. Wiley-Liss. 2017, Vol. 38, Issue 6.
  9. Reid C, Hildebrand MS, Mullen SA, Hildebrand JM, Berkovic S, Petrou S. Synaptic Zn2+ and febrile seizure susceptibility. BRITISH JOURNAL OF PHARMACOLOGY. Nature Publishing Group. 2017, Vol. 174, Issue 2.
  10. Allen AS, Bellows ST, Berkovic S, Bridgers J, Burgess R, Cavalleri G, Chung SK, Cossette P, Delanty N, Dlugos D, Epstein MP, Freyer C, Goldstein DB, Heinzen EL, Hildebrand MS, Johnson MR, Kuzniecky R, Lowenstein DH, Marson AG, Mayeux R, Mebane C, Mefford HC, O'Brien T, Ottman R, Petrou S, Petrovski S, Pickrell WO, Radtke RA, Rees MI, Regan BM, Ren Z, Scheffer I, Sills GJ, Thomas RH, Wang Q, Abou-Khalil B, Alldredge BK, Amrom D, Andermann E, Andermann F, Bautista JF, Bluvstein J, Boro A, Cascino GD, Consalvo D, Crumrine P, Devinsky O, Fiol M, Fountain NB, French J, Friedman D, Geller EB, Glauser T, Glynn S, Haas K, Haut SR, Hayward J, Helmers SL, Joshi S, Kanner A, Kirsch HE, Knowlton RC, Kossoff EH, Kuperman R, Motika PV, Novotny EJ, Paolicchi JM, Parent JM, Park K, Poduri A, Sadleir LG, Shellhaas RA, Sherr EH, Shih JJ, Shinnar S, Singh RK, Sirven J, Smith MC, Sullivan J, Thio LL, Venkat A, Vining EPG, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR. Ultra-rare genetic variation in common epilepsies: a case-control sequencing study. The Lancet Neurology. The Lancet Publishing Group. 2017, Vol. 16, Issue 2.
  11. Howden S, McColl B, Glaser A, Vadolas J, Petrou S, Little M, Elefanty A, Stanley E. A Cas9 Variant for Efficient Generation of Indel-Free Knockin or Gene-Corrected Human Pluripotent Stem Cells. STEM CELL REPORTS. Cell Press. 2016, Vol. 7, Issue 3.
  12. Hildebrand M, Myers CT, Carvill GL, Regan B, Damiano J, Mullen S, Newton M, Nair U, Gazina E, Milligan C, Reid C, Petrou S, Scheffer I, Berkovic S, Mefford HC. A targeted resequencing gene panel for focal epilepsy. NEUROLOGY. Lippincott Williams & Wilkins. 2016, Vol. 86, Issue 17.
  13. Phelan D, Anderson DJ, Howden S, Wong R, Hickey PF, Pope K, Wilson G, Pebay A, Davis A, Petrou S, Elefanty A, Stanley E, James P, MacCiocca I, Bahlo M, Cheung M, Amor D, Elliott D, Lockhart P. ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy(aEuro). EUROPEAN HEART JOURNAL. WB Saunders Co. 2016, Vol. 37, Issue 33.
  14. Myers CT, McMahon JM, Schneider AL, Petrovski S, Allen AS, Carvill GL, Zemel M, Saykally JE, Lacroix AJ, Heinzen EL, Hollingsworth G, Nikanorova M, Corbett M, Gecz J, Coman D, Freeman J, Calvert S, Gill D, Carney P, Lerman-Sagie T, Sampaio H, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Johnson MR, Kuzniecky R, Marson AG, O'Brien T, Ottman R, Petrou S, Poduri A, Pickrell WO, Chung SK, Rees MI, Sherr E, Sadleir LG, Goldstein DB, Lowenstein DH, M├śller RS, Berkovic S, Scheffer I, Mefford HC. De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies. American Journal of Human Genetics. University of Chicago Press. 2016, Vol. 99, Issue 2.
  15. Corbett MA, Bellows S, Li M, Carroll R, Micallef S, Carvill GL, Myers CT, Howell K, Maljevic S, Lerche H, Gazina E, Mefford HC, Bahlo M, Berkovic S, Petrou S, Scheffer I, Gecz J. Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy. NEUROLOGY. Lippincott Williams & Wilkins. 2016, Vol. 87, Issue 19.

View a full list of publications on the University of Melbourne’s ‘Find An Expert’ profile